GM CEO Is Under Fire From Trump, Lawmakers Over Restructuring 
 

General Motors Chief Executive Mary Barra faces bipartisan anger in Washington over the company's plans to cut 14,800 jobs and close four plants despite robust profits and a strong economy.

 
Tailored Brands Trims Outlook 
 

Tailored Brands Inc. lowered its outlook for the year after sales at its Men's Wearhouse business softened last month.

 
Cryptocurrency Startup Settles Fraud Accusations 
 

One of the first startups sued by U.S. regulators over its initial coin offering will pay $2.3 million after being accused of scamming investors through claims such as building a cryptocurrency bank.

 
Lowe's Adds $10 Billion to Stock Buyback Program 
 

Lowe's plans to increase its share buyback program by $10 billion, as the home-improvement retailer looks to turn investor sentiment and prove to Wall Street its business and growth plans are on solid footing.

 
U.K. Electricity-Network Operator National Grid Names CFO 
 

U.K. natural-gas and electricity-network operator National Grid appointed interim Chief Financial Officer Andy Agg as permanent finance chief.

 
CBS News Settles Harassment Suit From Three Colleagues of Charlie Rose 
 

CBS News settled a lawsuit, for undisclosed terms, brought by three women who alleged they were harassed by former on-air personality Charlie Rose.

 
New York's Russian Samovar Restaurant Files for Bankruptcy 
 

Russian Samovar Inc., a New York restaurant once co-owned by ballet legend Mikhail Baryshnikov and featured in the "Sex and the City" television series, has filed for bankruptcy, citing a $199,000 lease dispute.

 
P&G Buys Walker to Expand Offerings to African-Americans 
 

Procter & Gamble agreed to acquire Walker & Co. as the consumer-products giant looks to serve more African-Americans with health and beauty products.

 
Tencent Music Rises in Trading Debut 
 

Investors sounded notes of optimism about Tencent Music Entertainment Group, one of the biggest IPOs in the U.S. in recent years, pushing its shares 7.7% higher in the company's trading debut.

 
Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million 
 

Synergy Pharmaceuticals filed for bankruptcy with a plan to sell its assets to Bausch Health Companies for about $200 million in cash.

 
 

(END) Dow Jones Newswires

December 12, 2018 21:00 ET (02:00 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.